Clinical Trials Logo

Filter by:
NCT ID: NCT04553900 Completed - Hyperthermia Clinical Trials

Effect of Heat Stress on Global LV Function in Anesthetized Humans

Start date: June 9, 2017
Phase: N/A
Study type: Interventional

Recent data suggests that increased temperature improves inotropic function during systole and may improve diastolic function in healthy humans at rest, despite a reduction in left ventricular volume at end diastole. The effect of heat stress has not been reported in patients receiving general anesthesia and the impact of general anesthesia on these findings is not known. Trans-esophageal echocardiography will be used to measure parameters important to both systolic and diastolic function at temperature intervals of 1°C in patients undergoing "Heated Intraoperative Peritoneal Chemotherapy" (HIPEC.) That general anesthesia will not alter the cardiovascular effects of increased temperature that has been reported in healthy, un-anesthetized humans is the hypothesis.

NCT ID: NCT04553848 Completed - Clinical trials for Traumatic Brain Injury

Augmented Reality and Treadmill Training After Traumatic Brain Injury

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

Up to 40 participants will be enrolled in this study in order to obtain complete data on 30 participants. The investigators will be assessing if Augmented reality in combination with treadmill training is safe and feasible to use in the clinical environment with participants who have chronic TBI and if there is a signal of effect that this intervention may be more beneficial than treadmill training alone or standard of care.

NCT ID: NCT04553679 Completed - Stroke Clinical Trials

Mindfulness After Stroke

Start date: October 1, 2020
Phase:
Study type: Observational

The purpose of this study is to test the relevance, satisfaction and ease-of-use of an online mindfulness intervention among stroke survivors and their caregivers. Quality of life, depression, anxiety, stress and sleep quality will be assessed before, after and at 1 month after the intervention. After the intervention, participants' feedback about the usability and the satisfaction with the intervention and the online program will be gathered. Based on participants' feedback, changes to the intervention will be made to obtain a final version.

NCT ID: NCT04553666 Completed - Inflammation Clinical Trials

Reducing Frailty for Older Cancer Survivors Using Supplements

ReFOCUS
Start date: March 15, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study is to examine the feasibility and safety of twelve weeks oral supplementation of Epigallocatechin-3-gallate (EGCG) in older survivors of cancer

NCT ID: NCT04553640 Completed - Stroke Clinical Trials

Virtual Patient Education From Real Cases

ViPER
Start date: May 15, 2021
Phase: N/A
Study type: Interventional

Misdiagnosis of neurological conditions is common in healthcare settings, sometimes with devastating consequences. Most diagnostic errors result from failures in bedside diagnostic reasoning. Dizziness is a symptom that is common, costly, and frequently associated with missed stroke. Too often healthcare providers have misconceptions about diagnostic approaches to dizziness. Current systems of medical education, residency training, and licensure requirements have proven insufficient to prevent harms from diagnostic error. Traditional lectures do not change physician behavior but active learning strategies with the use of simulation do. The investigators built and hope to expand a simulation-based curriculum to improve diagnosis of dizziness (SIDD) that will mirror real-world encounters and clinical practice. Using the tenets of deliberate practice with rapid, real-time feedback, the investigators hope to improve the approach to dizziness of healthcare providers and correct knowledge deficits that contribute to diagnostic errors. Investigators have chosen dizziness as the "model symptom" for this study. Future plans include expanding this approach to other symptoms that are also common, costly, and associated with a high misdiagnosis rate (e.g. abdominal pain, dyspnea, or chest pain).

NCT ID: NCT04553588 Completed - Drug Prescriptions Clinical Trials

Effect of an Opioid Disposal Pouch Versus Usual Care on Post Discharge Disposal of Unused Medication

Start date: July 15, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if opioid disposal bags/pouches are an effective method for disposing of unused opioid medications postoperatively

NCT ID: NCT04553549 Completed - Stroke, Acute Clinical Trials

Safety and Feasibility of the Infinity Catheter for Radial Access

Start date: October 1, 2020
Phase:
Study type: Observational

The main objective of this single arm study is to evaluate the safety and feasibility of the AXS Infinity LS (Stryker, Freemont, CA, USA) and AXS Infinity LS Plus (Stryker, Freemont, CA, USA) catheters during the transradial approach through a secondary use of the data collected during neurointerventional procedures. This includes evaluating the conversion rates to a transfemoral approach. A secondary aim of the study is to assess the radial artery occlusion rates post procedure.

NCT ID: NCT04553484 Completed - D012039 Clinical Trials

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods

Start date: August 5, 2020
Phase: N/A
Study type: Interventional

The aims of this study are to measure cardiovascular performance and blood flow using common but never compared methods.

NCT ID: NCT04553471 Completed - Sarcoma Clinical Trials

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

Start date: September 22, 2020
Phase: N/A
Study type: Interventional

This is a study evaluating the safety and efficacy of Lattice SBRT for patients with large tumors (≥ 4.5 cm) planning to undergo palliative radiotherapy.

NCT ID: NCT04553445 Completed - Migraine Disorders Clinical Trials

Temporal, Environmental, and Genetic Factors Regulating Exercise and Migraine

Start date: November 23, 2020
Phase: N/A
Study type: Interventional

Chronic pain, of which migraine is among the most common, affects 100 million US adults and costs between $560 to $635 billion dollars annually. There is a need for effective, low-cost non-pharmacological strategies to reduce migraine load in migraineurs (based on International Headache Society classification International Classification of Headache Disorders [ICHD]-3; experience headache [migraine-like or tension-type-like] on 15+ days/month for 3+ months, and have migraine headaches [either with aura or without aura] on 8+ days/month). This represents an area of interest, as common migraine medications induce central nervous system side-effects including aphasia, ataxia, somnolescence, and vertigo; and 79% of suffers have an interest in trying novel treatment strategies with lower adverse effects than medications. Exercise has been shown to be a non-pharmacological intervention to reduce migraine burden. However, how environmental (i.e. - time-of-day, exposure to nature) and genetic factors (i.e. - polymorphisms in circadian and migraine associated genes) impact the laudatory effects of exercise remains unknown. There are independently established heritable components to migraine frequency (65%), circadian rhythm (70%), and aerobic power during exercise (66%). Thus, the central hypothesis is that an optimal environment can improve the exercise-induced reduction in migraine load, which is influenced by genetic heritability of migraine related gene polymorphisms.